Ethnic Kawasaki disease risk associated with blood mercury and cadmium in U.S. children

International Journal of Environmental Research and Public Health

Volumn 13, Issue 1, 2016, Pages

  Yeter, Deniz ^a   Portman, Michael A ^b   Aschner, Michael ^c   Farina, Marcelo ^d   Chan, Wen Ching ^a   Hsieh, Kai Sheng ^a,e   Kuo, Ho Chang ^a,e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^e CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Allergy; Autoimmunity; Infantile acrodynia; Kawasaki disease; Mercury; Methylmercury; Pediatrics; Pollution; Seafood; Toxicology

Indexed keywords

CADMIUM; METHYLMERCURY; MERCURY;

ALLERGY; BLOOD; CADMIUM; CHILD HEALTH; DISEASE INCIDENCE; ETHNICITY; HEALTH RISK; IMMUNITY; MERCURY (ELEMENT); TOXICITY;

AFRICAN; ARTICLE; ASIAN; BLOOD ANALYSIS; CADMIUM POISONING; CAUCASIAN; CHILD; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; ETHNIC DIFFERENCE; FEMALE; FOOD INTAKE; HISPANIC; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MERCURIALISM; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK FACTOR; SEA FOOD; UNITED STATES; ASIAN CONTINENTAL ANCESTRY GROUP; BLACK PERSON; BLOOD; COMPARATIVE STUDY; ETHNOLOGY; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; TOXICITY;

UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CADMIUM; CHILD, PRESCHOOL; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INFANT; MALE; MERCURY; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK FACTORS; SEAFOOD; UNITED STATES;

EID: 84953716542     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13010101     Document Type: Article

References (75)

1. Guo, M.M.; Tseng, W. N.; Ko, C.H.; Pan, H.M.; Hsieh, K.S.; Kuo, H.C. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy 2015, 70, 310-318. [CrossRef] [PubMed]
2. Kuo, H.C.; Hsu, Y.W.; Wu, M.S.; Chien, S.C.; Liu, S.F.; Chang, W.C. Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease. J. Microbiol. Immunol. Infect. 2014. [CrossRef] [PubMed]
3. Ruan, Y.; Ye, B.; Zhao, X. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Pediatr. Infect. Dis. J. 2013, 32, e397-e402. [CrossRef] [PubMed]
4. Newburger, J.W.; Takahashi, M.; Gerber, M.A.; Gewitz, M.H.; Tani, L.Y.; Burns, J.C.; Shulman, S.T.; Bolger, A.F.; Ferrieri, P.; Baltimore, R.S.; et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004, 110, 2747-2771. [CrossRef] [PubMed]
5. Mason, W.H.; Takahashi, M. Kawasaki syndrome. Clin. Infect. Dis. 1999, 28, 169-185. [CrossRef] [PubMed]
6. Makino, N.; Nakamura, Y.; Yashiro, M.; Ae, R.; Tsuboi, S.; Aoyama, Y.; Kojo, T.; Uehara, R.; Kotani, K.; Yanagawa, H. Descriptive epidemiology of kawasaki disease in Japan, 2011-2012: From the results of the 22nd nationwide survey. J. Epidemiol. 2015, 25, 239-245. [CrossRef] [PubMed]
7. Kim, G.B.; Han, J.W.; Park, Y.W.; Song, M.S.; Hong, Y.M.; Cha, S.H.; Kim, D.S.; Park, S. Epidemiologic features of Kawasaki disease in South Korea: Data from nationwide survey, 2009-2011. Pediatr. Infect. Dis. J. 2014, 33, 24-27. [CrossRef] [PubMed]
8. Huang, S.K.; Lin, M.T.; Chen, H.C.; Huang, S.C.; Wu, M.H. Epidemiology of Kawasaki disease: Prevalence from national database and future trends projection by system dynamics modeling. J. Pediatr. 2013, 163, 126-131. [CrossRef] [PubMed]
9. Uehara, R.; Belay, E.D. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J. Epidemiol. 2012, 22, 79-85. [CrossRef] [PubMed]
10. Holman, R.C.; Christensen, K.Y.; Belay, E.D.; Steiner, C.A.; Effler, P.V.; Miyamura, J.; Forbes, S.; Schonberger, L.B.; Melish, M. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med. J. 2010, 69, 194-197. [PubMed]
11. Duan, J.; Lou, J.; Zhang, Q.; Ke, J.; Qi, Y.; Shen, N.; Zhu, B.; Zhong, R.; Wang, Z.; Liu, L.; et al. A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: A case-control study and meta-analysis. PLoS ONE 2014, 9. [CrossRef]
12. Kuo, H.C.; Hsu, Y.W.; Lo, M.H.; Huang, Y.H.; Chien, S.C.; Chang, W.C. Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki disease. PLoS ONE 2014, 9. [CrossRef]
13. Xing, Y.; Wang, H.; Liu, X.; Yu, X.; Chen, R.; Wang, C.; Sun, L. Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease. Mol. Biol. Rep. 2014, 41, 6377-6381. [CrossRef] [PubMed]
14. Chang, C.J.; Kuo, H.C.; Chang, J.S.; Lee, J.K.; Tsai, F.J.; Khor, C.C.; Chang, L.C.; Chen, S.P.; Ko, T.M.; Liu, Y.M, et al. Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS ONE 2013, 8. [CrossRef] [PubMed]
15. Peng, Q.; Chen, C.H.; Wu, Q.; Yang, Y. Meta-analyses of the associations of genome-wide association study-linked gene loci with Kawasaki disease. Chin. J. Pediatr. 2013, 51, 571-577.
16. Lou, J.; Xu, S.; Zou, L.; Zhong, R.; Zhang, T.; Sun, Y.; Lu, X.; Liu, L.; Li, C.; Wang, L, et al. A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: An integrated meta-analysis. Mol. Biol. Rep. 2012, 39, 11137-11144. [CrossRef] [PubMed]
17. Lee, Y.C.; Kuo, H.C.; Chang, J.S.; Chang, L.Y.; Huang, L.M.; Chen, M.R.; Liang, C.D.; Chi, H.; Huang, F.Y.; Lee, M.L, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat. Genet. 2012, 44, 522-525. [CrossRef] [PubMed]
18. Khor, C.C.; Davila, S.; Breunis, W.B.; Lee, Y.C.; Shimizu, C.; Wright, V.J.; Yeung, R.S.; Tan, D.E.; Sim, K.S.; Wang, J.J, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat. Genet. 2011, 43, 1241-1246. [CrossRef] [PubMed]
19. Onouchi, Y. Genetics of Kawasaki disease: What we know and don’t know. Circ. J. 2012, 76, 1581-1586. [CrossRef] [PubMed]
20. Yeter, D.; Deth, R. ITPKC susceptibility in Kawasaki syndrome as a sensitizing factor for autoimmunity and coronary arterial wall relaxation induced by thimerosal’s effects on calcium signaling via IP3. Autoimmun. Rev. 2012, 11, 903-908. [CrossRef] [PubMed]
21. Chang, L.Y.; Lu, C.Y.; Shao, P.L.; Lee, P.I.; Lin, M.T.; Fan, T.Y.; Cheng, A.L.; Lee, W. L.; Hu, J.J.; Yeh, S.J, et al. Viral infections associated with Kawasaki disease. J. Formos. Med. Assoc. 2014, 113, 148-154. [CrossRef] [PubMed]
22. Turnier, J.L.; Anderson, M.S.; Heizer, H.R.; Jone, P.N.; Glode, M.P.; Dominguez, S.R. Concurrent respiratory viruses and Kawasaki disease. Pediatrics 2015, 136, e609-e614. [CrossRef] [PubMed]
23. Jaggi, P.; Kajon, A.E.; Mejias, A.; Ramilo, O.; Leber, A. Human adenovirus infection in Kawasaki disease: A confounding bystander? Clin. Infect. Dis. 2013, 56, 58-64. [CrossRef] [PubMed]
24. Jordan-Villegas, A.; Chang, M.L.; Ramilo, O.; Mejias, A. Concomitant respiratory viral infections in children with Kawasaki disease. Pediatr. Infect. Dis. J. 2010, 29, 770-772. [CrossRef] [PubMed]
25. Cheek, D.B. Letter: Comment on mucocutaneous lymph node syndrome: Could it be a heavy metal poisoning? Pediatrics 1975, 56, 335-336. [PubMed]
26. Nishida, G. Letter: Mercury poisoning and MLNS. Pediatrics 1976, 58. [CrossRef]
27. Adler, R.; Boxstein, D.; Schaff, P.; Kelly, D. Metallic mercury vapor poisoning simulating mucocutaneous lymph node syndrome. J. Pediatr. 1982, 101, 967-968. [CrossRef]
28. Orlowski, J.P.; Mercer, R.D. Urine mercury levels in Kawasaki disease. Pediatrics 1980, 66, 633-636. [PubMed]
29. Kawasaki, T. Letter To The Editor. Pediatrics 1975, 56, 336-337.
30. Aschner, M.; Aschner, J.L. Mucocutaneous lymph node syndrome: Is there a relationship to mercury exposure? Am. J. Dis. Child. 1989, 143, 1133-1134. [CrossRef] [PubMed]
31. Warkany, J.; Hubbard, D.M. Adverse mercurial reactions in the form of acrodynia and related conditions, AMA. Am. J. Dis. Child. 1951, 81, 335-373.
32. Warkany, J.; Hubbard, D.M. Acrodynia and mercury. J. Pediatr. 1953, 42, 365-386. [CrossRef]
33. The Kids’ Inpatient Database (KID). Available online:http://hcup-us.ahrq.gov/kidoverview.jsp (accessed on 15 February 2015).
34. The National Health and Nutrition Examination Survey. Available online: http://www.cdc.gov/nchs/nhanes.htm (accessed on 15 February 2015).
35. Holman, R.C.; Curns, A.T.; Belay, E.D.; Steiner, C.A.; Schonberger, L.B. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 2003, 112, 495-501. [CrossRef] [PubMed]
36. Holman, R.C.; Belay, E.D.; Christensen, K.Y.; Folkema, A.M.; Steiner, C.A.; Schonberger, L.B. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr. Infect. Dis. J. 2010, 29, 483-488. [CrossRef] [PubMed]
37. Woon, P.Y.; Chang, W.C.; Liang, C.C.; Hsu, C.H.; Klahan, S.; Huang, Y.H.; Chang, W.P.; Kuo, H.C. Increased risk of atopic dermatitis in preschool children with Kawasaki disease: A population-based study in Taiwan. Evid. Based Complement. Alternat. Med. 2013, 2013. [CrossRef] [PubMed]
38. Wei, C.C.; Lin, C.L.; Kao, C.H.; Liao, Y.H.; Shen, T.C.; Tsai, J.D.; Chang, Y.J.; Li, T.C. Increased risk of Kawasaki disease in children with common allergic diseases. Ann. Epidemiol. 2014, 24, 340-343. [CrossRef] [PubMed]
39. Tsai, Y.J.; Lin, C.H.; Fu, L.S.; Fu, Y.C.; Lin, M.C.; Jan, S.L. The association between Kawasaki disease and allergic diseases, from infancy to school age. Allergy Asthma Proc. 2013, 34, 467-472. [CrossRef] [PubMed]
40. Jung, D.Y.; Leem, J.H.; Kim, H.C.; Kim, J.H.; Hwang, S.S.; Lee, J.Y.; Kim, B.J.; Hong, Y.C.; Hong, S.J.; Kwon, H.J. Effect of Traffic-Related Air Pollution on Allergic Disease: Results of the Children’s Health and Environmental Research. Allergy Asthma Immunol. Res. 2015, 7, 359-366. [CrossRef] [PubMed]
41. Kim, H.H.; Lee, C.S.; Jeon, J.M.; Yu, S.D.; Lee, C.W.; Park, J.H.; Shin, D.C.; Lim, Y.W. Analysis of the association between air pollution and allergic diseases exposure from nearby sources of ambient air pollution within elementary school zones in four Korean cities. Environ. Sci. Pollut. Res. Int. 2013, 20, 4831-4846. [CrossRef] [PubMed]
42. Feleszko, W.; Ruszczynski, M.; Jaworska, J.; Strzelak, A.; Zalewski, B.M.; Kulus, M. Environmental tobacco smoke exposure and risk of allergic sensitisation in children: A systematic review and meta-analysis. Arch. Dis. Child. 2014, 99, 985-992. [CrossRef] [PubMed]
43. Thacher, J.D.; Gruzieva, O.; Pershagen, G.; Neuman, A.; Wickman, M.; Kull, I.; Melen, E.; Bergstrom, A. Pre- and postnatal exposure to parental smoking and allergic disease through adolescence. Pediatrics 2014, 134, 428-434. [CrossRef] [PubMed]
44. Awaya, A.; Nishimura, C. A combination of cross correlation and trend analyses reveals that Kawasaki disease is a pollen-induced delayed-type hyper-sensitivity disease. Int. J. Environ. Res. Public Health 2014, 11, 2628-2641. [CrossRef] [PubMed]
45. Rodo, X.; Ballester, J.; Cayan, D.; Melish, M.E.; Nakamura, Y.; Uehara, R.; Burns, J.C. Association of Kawasaki disease with tropospheric wind patterns. Sci. Rep. 2011, 1. [CrossRef] [PubMed]
46. Rodo, X.; Curcoll, R.; Robinson, M.; Ballester, J.; Burns, J.C.; Cayan, D.R.; Lipkin, W.I.; Williams, B.L.; Couto-Rodriguez, M.; Nakamura, Y, et al. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc. Natl. Acad. Sci. USA 2014, 111, 7952-7957. [CrossRef] [PubMed]
47. Chen, H.; Teng, Y.; Lu, S.; Wang, Y.; Wang, J. Contamination features and health risk of soil heavy metals in China. Sci. Total Environ. 2015, 512-513, 143-153. [CrossRef] [PubMed]
48. Baba, H.; Tsuneyama, K.; Kumada, T.; Aoshima, K.; Imura, J. Histopathological analysis for osteomalacia and tubulopathy in itai-itai disease. J. Toxicol. Sci. 2014, 39, 91-96. [CrossRef] [PubMed]
49. Grandjean, P.; Satoh, H.; Murata, K.; Eto, K. Adverse effects of methylmercury: Environmental health research implications. Environ. Health Perspect. 2010, 118, 1137-1145. [CrossRef] [PubMed]
50. Shibuya, N.; Shibuya, K.; Kato, H.; Yanagisawa, M. Kawasaki disease before kawasaki at Tokyo university hospital. Pediatrics 2002, 110. [CrossRef]
51. Tashyrev, O.B.; Ie, P.P.; Tashyreva, G.O.; Bielikova, O. Resistance of microbial communities from ecuador ecosystems to representative toxic metals-CrO4(2_), Co2+, Ni2+, Cu2+, Hg2+. Mikrobiol. Z. 2015, 77, 44-61. [PubMed]
52. Jiang, C.B.; Hsi, H.C.; Fan, C.H.; Chien, L.C. Fetal exposure to environmental neurotoxins in Taiwan. PLoS ONE 2014, 9. [CrossRef] [PubMed]
53. Diez, S.; Delgado, S.; Aguilera, I.; Astray, J.; Perez-Gomez, B.; Torrent, M.; Sunyer, J.; Bayona, J.M. Prenatal and early childhood exposure to mercury and methylmercury in Spain, a high-fish-consumer country. Arch. Environ. Contam. Toxicol. 2009, 56, 615-622. [CrossRef] [PubMed]
54. Ralston, N.V.; Ralston, C.R.; Blackwell, J.L., 3rd; Raymond, L.J. Dietary and tissue selenium in relation to methylmercury toxicity. Neurotoxicology 2008, 29, 802-811. [CrossRef] [PubMed]
55. Choi, A.L.; Budtz-Jorgensen, E.; Jorgensen, P.J.; Steuerwald, U.; Debes, F.; Weihe, P.; Grandjean, P. Selenium as a potential protective factor against mercury developmental neurotoxicity. Environ. Res. 2008, 107, 45-52. [CrossRef] [PubMed]
56. Pichichero, M.E.; Gentile, A.; Giglio, N.; Umido, V.; Clarkson, T.; Cernichiari, E.; Zareba, G.; Gotelli, C.; Gotelli, M.; Yan, L, et al. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics 2008, 121, e208-e214. [CrossRef] [PubMed]
57. Xue, J.; Zartarian, V.G.; Liu, S.V.; Geller, A.M. Methyl mercury exposure from fish consumption in vulnerable racial/ethnic populations: Probabilistic SHEDS-Dietary model analyses using 1999-2006 NHANES and 1990-2002 TDS data. Sci. Total Environ. 2012, 414, 373-379. [CrossRef] [PubMed]
58. Lue, H.C.; Chen, L.R.; Lin, M.T.; Chang, L.Y.; Wang, J.K.; Lee, C.Y.; Wu, M.H. Epidemiological features of Kawasaki disease in Taiwan, 1976-2007: Results of five nationwide questionnaire hospital surveys. Pediatr. Neonatol. 2014, 55, 92-96. [CrossRef] [PubMed]
59. Nielsen, S.J.; Aoki, Y.; Kit, B.K.; Ogden, C.L. More than half of US youth consume seafood and most have blood mercury concentrations below the EPA reference level, 2009-2012. J. Nutr. 2015, 145, 322-327. [CrossRef] [PubMed]
60. Caldwell, K.L.; Mortensen, M.E.; Jones, R.L.; Caudill, S.P.; Osterloh, J.D. Total blood mercury concentrations in the U.S. population: 1999-2006. Int. J. Hyg. Environ. Health 2009, 212, 588-598. [CrossRef] [PubMed]
61. Portman, M.A. Kawasaki disease and soy: Potential role for isoflavone interaction with Fcgamma receptors. Pediatr. Res. 2013, 73, 130-134. [CrossRef] [PubMed]
62. Shrestha, S.; Wiener, H.; Shendre, A.; Kaslow, R. A.; Wu, J.; Olson, A.; Bowles, N.E.; Patel, H.; Edberg, J.C.; Portman, M.A. Role of activating Fcgamma R gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response. Circ. Cardiovasc. Genet. 2012, 5, 309-316. [CrossRef] [PubMed]
63. Chen, Z.; Myers, R.; Wei, T.; Bind, E.; Kassim, P.; Wang, G.; Ji, Y.; Hong, X.; Caruso, D.; Bartell, T. et al. Placental transfer and concentrations of cadmium, mercury, lead, and selenium in mothers, newborns, and young children. J. Expo. Sci. Environ. Epidemiol. 2014, 24, 537-544. [CrossRef] [PubMed]
64. Arefieva, A.S.; Kamaeva, A.G.; Krasilshchikova, M.S. Low doses of mercuric chloride cause the main features of antinucleolar autoimmune process in female outbred CFW mice. Toxicol. Ind. Health 2015. [CrossRef] [PubMed]
65. Havarinasab, S.; Bjorn, E.; Ekstrand, J.; Hultman, P. Dose and Hg species determine the T-helper cell activation in murine autoimmunity. Toxicology 2007, 229, 23-32. [CrossRef] [PubMed]
66. Zheng, Y.; Gallucci, S.; Gaughan, J.P.; Gross, J.A.; Monestier, M. A role for B cell-activating factor of the TNF family in chemically induced autoimmunity. J. Immunol. 2005, 175, 6163-6168. [CrossRef] [PubMed]
67. Toomey, C.B.; Cauvi, D.M.; Hamel, J.C.; Ramirez, A.E.; Pollard, K.M. Cathepsin B regulates the appearance and severity of mercury-induced inflammation and autoimmunity. Toxicol. Sci. 2014, 142, 339-349. [CrossRef] [PubMed]
68. Häggqvist, B.; Havarinasab, S.; Björn, E.; Hultman, P. The immunosuppressive effect of methylmercury does not preclude development of autoimmunity in genetically susceptible mice. Toxicology 2005, 208, 149-164. [CrossRef] [PubMed]
69. Havarinasab, S.; Lambertsson, L.; Qvarnstrom, J.; Hultman, P. Dose-response study of thimerosal-induced murine systemic autoimmunity. Toxicol. Appl. Pharmacol. 2004, 194, 169-179. [CrossRef] [PubMed]
70. Sapin, C.; Hirsch, F.; Delaporte, J.P.; Bazin, H.; Druet, P. Polyclonal IgE increase after HgCl2 injections in BN and LEW rats: A genetic analysis. Immunogenetics 1984, 20, 227-236. [CrossRef] [PubMed]
71. De Castro, N.S.; Mde, O.L. Biomarkers of mercury exposure in the Amazon. Biomed. Res. Int. 2014, 2014. [CrossRef] [PubMed]
72. Motts, J.A.; Shirley, D.L.; Silbergeld, E.K.; Nyland, J.F. Novel biomarkers of mercury-induced autoimmune dysfunction: A cross-sectional study in Amazonian Brazil. Environ. Res. 2014, 132, 12-18. [CrossRef] [PubMed]
73. Gardner, R.M.; Nyland, J.F.; Silva, I.A.; Ventura, A.M.; de Souza, J.M.; Silbergeld, E.K. Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: A cross-sectional study. Environ. Res. 2010, 110, 345-354. [CrossRef] [PubMed]
74. Silva, I.A.; Nyland, J.F.; Gorman, A.; Perisse, A.; Ventura, A.M.; Santos, E.C.; Souza, J.M.; Burek, C.L.; Rose, N.R.; Silbergeld, E.K. Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in Amazon populations in Brazil: A cross-sectional study. Environ. Health 2004, 3. [CrossRef] [PubMed]
75. Gattineni, J.; Weiser, S.; Becker, A.M.; Baum, M. Mercury intoxication: Lack of correlation between symptoms and levels. Clin. Pediatr. 2007, 46, 844-846. [CrossRef] [PubMed]